Biological patch, preparation method therefor, and use thereof

By oxidative polymerization of polyphenol compounds and chelation of active metal ions on the matrix of biological patches, foreign body reaction and biocompatibility problems in collagen-based tissue damage repair are solved, and efficient antibacterial and vasoactive activities are achieved. Regeneration in soft tissue and abdominal wall.

WO2024234340A1PCT designated stage expired Publication Date: 2024-11-21BEIJING BIOSIS HEALING BIOLOGICAL TECH CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2023/094851
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-17
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

Existing biological patches have foreign body reactions, tissue adhesions and adverse regeneration effects in collagen-based tissue damage repair, and the biocompatibility of traditional materials is insufficient, resulting in a high risk of bacterial infection and visceral adhesions.

Method used

Using a matrix with a fibrous filament structure, chelating sites are formed by oxidative polymerization of polyphenol compounds, and chemically chelating active metal ions such as copper ions on the surface or inside the matrix to prepare excellent biocompatibility, antibacteriality and Biopipettes for vascularization.

Benefits of technology

It achieves the ideal healing effect of untied adhesions, significantly improves antibacterial efficiency and vasoactive activity, is suitable for mass production, and is suitable for soft tissue repair and abdominal wall regeneration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2023094851_21112024_PF_FP_ABST
    Figure CN2023094851_21112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention provides a biological patch, a preparation method therefor, and a use thereof. The biological patch of the present invention comprises: a matrix, wherein the matrix has a fiber filament structure, and chelating sites are provided on the surface of the matrix and / or inside the matrix; and active metal ions, wherein on the basis of the chelating sites, the active metal ions are chemically chelated on the surface of the matrix and / or inside the matrix, and the chelating sites are obtained by oxidative polymerization of a polyphenol compound on the surface of the matrix and / or inside the matrix. The biological patch of the present invention has excellent biocompatibility, excellent antibacterial performance and excellent vascularization capability, realizes ideal healing promotion results, and has no tissue adhesions.
Need to check novelty before this filing date? Find Prior Art

Description

Biological patch and its preparation method and use Technical Field The invention relates to a biological patch and a preparation method and application thereof, belonging to the field of medical materials. Background Art Surgical trauma to the abdominal wall, chest wall, and dura mater, primary or secondary tumor resection, and tissue infection add more than $10 billion and 400,000-fold to the surgical burden on surgeons and patients. In recent years, repair of collagen-based soft tissue injuries caused by damage to the serosa and muscular layer has become an unprecedented challenge, and serosa injuries often lead to severe visceral adhesions and hernias. For decades, tension-free repair surgery has become the standard for soft tissue repair (e.g., abdominal wall injuries), and different types of patches have been commercialized and widely used in clinical practice. Synthetic patches with high mechanical strength and light weight (e.g., polypropylene (PP), polyester patches) are currently used for tension-free surgical repairs, especially hernia repairs. However, the obvious foreign body reaction and porous design of these patches usually lead to the above-mentioned severe tissue adhesion and poor regeneration effect. A common strategy for addressing this poor tissue regeneration is to manufacture patches with antibacterial and provascularization expression to prevent bacterial infection and promote collagen maturation for tissue remodeling and repair. For example, silver nanoparticles, zinc ions, antibiotics, and antimicrobial peptides have been loaded onto tissue engineering scaffolds and have been shown to have strong antibacterial properties both in vitro and in vivo. However, simply loading antimicrobial biomaterials still shows limited ideal regenerative results. Especially for collagen-based tissue injuries, the located tissue is highly correlated with the vascularization state, because the neovascular system promotes nutrient transport and alleviates ischemia and hypoxia, thereby integrating drugs and bioactive ions with vasoactive functions into scaffold materials to induce tissue regeneration. It is worth noting that with the increase of biomaterial components such as antimicrobial and vasoactive drugs or ions mentioned above, the instability and complexity of research and design have increased the burden on researchers to effectively transform biomedicine into medical devices. Therefore, in the future, designing a new type of biomaterial will be more attractive and competitive. It is worth noting that some biologically active ions have two or three properties, but the types are very limited. 2+ ) have been shown to have vasculogenic activity, osteogenic activity and the ability to regulate the polarization phenotype of macrophages. 4+ ) can accelerate angiogenesis and collagen deposition. However, due to its small atomic radius, Mg 2+ and Si 4+ It is difficult to chemically bond with other matrices, resulting in low binding energy. Therefore, when they are mixed with scaffold materials in the form of magnesium oxide, magnesium carbonate, and silicate, there are potential biocompatibility issues due to the burst release of ions exceeding cell tolerance. Traditional commercial PP patches are limited by their low cell compatibility, which is not conducive to the infiltration and adhesion of native cells, resulting in high risk of visceral tissue adhesion and bacterial infection. Therefore, the preparation of a biological patch with excellent biocompatibility, antibacterial and vascularization ability, achieving the ideal healing-promoting results and no tissue adhesion has become a technical problem to be solved urgently. Summary of the invention Problem that the invention aims to solve In view of the technical problems existing in the prior art, the present invention first provides a biological patch. The biological patch of the present invention has excellent biocompatibility, antibacterial property and vascularization ability, and achieves an ideal healing promotion result without tissue adhesion. Furthermore, the present invention also provides a method for preparing a biological patch, which is simple and easy to implement, and the raw materials are easy to obtain, and is suitable for mass production. Solutions for solving problems [1] A biological patch comprising: A matrix having a fiber structure and having chelating sites on the surface and / or inside of the matrix; and Active metal ions, based on the chelating sites, the active metal ions are chemically chelated on the surface and / or inside of the matrix; and, The chelating sites are obtained by oxidative polymerization of polyphenolic compounds on the surface and / or inside of the matrix. [2] The biological patch according to [1] above, wherein, based on the total mass of the biological patch being 100%, the carbon content is 70-85%, the nitrogen content is 5-10%, the oxygen content is 5-20%, and the active metal ion content is 0.05-5%. [3] The biological patch according to [1] or [2] above, wherein the matrix is ​​derived from a biodegradable biological material, preferably comprising collagen; and / or The active metal ions include one or a combination of two or more of copper ions, calcium ions, manganese ions, zinc ions, chromium ions, cobalt ions, strontium ions, and iron ions. [4] The biological patch according to any one of [1] to [3] above, wherein the polyphenol compound comprises one or a combination of two or more of dopamine, tannic acid, catechol, pyrogallol, gallic acid and catechin. [5] A method for preparing a biological patch according to any one of [1] to [4] above, comprising the step of chemically chelating active metal ions on the surface and / or inside of a matrix using a polyphenol compound. [6] The preparation method according to [5] above, wherein the preparation method comprises the following steps: oxidatively polymerizing the polyphenolic compound on the surface and / or inside of the substrate to form chelating sites; Based on the chelating sites, the active metal ions are chemically chelated on the surface and / or inside of the matrix. [7] The preparation method according to [6] above, wherein the preparation method comprises the following steps: dissolving the polyphenolic compound in a buffer solution to obtain a solution containing the polyphenolic compound; The substrate is immersed in the solution containing the polyphenol compound to perform oxidative polymerization to obtain an intermediate having a chelating site; preparing a solution containing active metal ions; The intermediate with the chelating site is immersed in a solution containing active metal ions for chemical chelation to obtain a biological patch. [8] The preparation method according to [7] above, wherein the concentration of the polyphenolic compound in the solution containing the polyphenolic compound is 0.1-10 mg mL -1 and / or, In the solution containing active metal ions, the mass concentration of active metal ions is 0.01-0.5%. [9] The preparation method according to [7] or [8] above, wherein the oxidative polymerization time is 12-36 hours; and / or The chemical chelation time is 12-36 hours.

[0010] , Use of the biological patch according to any one of [1]-[4] above in the preparation of soft tissue repair products and abdominal wall regeneration and repair products. Effects of the Invention The biological patch of the present invention has excellent biocompatibility, antibacterial properties and vascularization ability, and achieves an ideal healing promotion result without tissue adhesion. Furthermore, the preparation method of the biological patch of the present invention is simple and easy to implement, the raw materials are easy to obtain, and it is suitable for mass production. BRIEF DESCRIPTION OF THE DRAWINGS FIG1 shows a schematic diagram of the preparation process of a biological patch of the present invention, an electron microscope image and an elemental surface scan image; wherein, a is a schematic diagram of the preparation process of the SIS / PDA / Cu biological patch of Example 1; b is the SEM images of SIS, SIS / PDA, and SIS / PDA / Cu biological patches (where the inset is the general appearance of the patch); c is the elemental surface scan of SIS, SIS / PDA, and SIS / PDA / Cu biological patches. FIG2 shows the physical and mechanical properties of the SIS / PDA / Cu, SIS / PDA and SIS biopatch in Example 1; wherein, a is the X-ray photoelectron spectroscopy (XPS) curve and the high-resolution spectrum of copper element of SIS / PDA / Cu; b is the water contact angle of the biological patch after reaching equilibrium at room temperature; c is the tensile stress-strain behavior of the biological patch; d is the ultimate tensile strength (UTS) of the biological patch; e is the elongation at break; f is the calculation of Young's modulus. FIG3 shows the test results of the DPPH scavenging ability of SIS, SIS / PDA, and SIS / PDA / Cu biopatches. FIG4 shows the antibacterial ability of SIS, SIS / PDA, and SIS / PDA / Cu biopatch; wherein, a is the bacterial colony formation when bacteria (Escherichia coli or Staphylococcus aureus) are co-cultured with the biopatch, and the recovered supernatant is placed on a sterile agar plate for 24 h; b is the bacterial activity in the supernatant, measured by OD 600 Value record; c shows the bacterial morphology on the biological patch. ***P≤0.001. Figure 5 shows the Cu 2+ Release test results; among them, a is Cu 2+ Schematic diagram of the effect of release potential on pH value; b is Cu 2+ The daily release trend chart during the 14-day release process; FIG6 shows the cell compatibility and vascular activity of SIS, SIS / PDA, and SIS / PDA / Cu biopatch; wherein, a shows live / dead staining of L929 fibroblasts on different substrates for 24 h; b is the activity of L929 on the substrate for 24 h; c shows the cytoskeleton staining of L929 cells on the biological patch for 24 hours; d is a semi-quantitative analysis of the cell spreading area based on c; e, HIF-α and CD31 immunofluorescence staining of L929 on the biopatch for 14 days; f is a semi-quantitative analysis based on the fluorescence intensity of e, *P≤0.05, **P≤0.01, ***P≤0.001. FIG7 shows a photograph of a commercially available PP patch; FIG8 shows a rat abdominal wall defect model for evaluating abdominal wall regeneration; wherein, a To create a 1-cm-long abdominal wall defect, surgical nylon was used to fix the implant (2 cm long and 1 cm wide) at the injury site; b is a low resolution H&E staining of the abdominal wall tissue located on day 7; c is a high-resolution image of H&E staining on the abdominal wall tissue located on day 7; d is Masson trichrome staining of the located abdominal wall tissue on day 7; e is CD31 immunohistochemical staining performed on the located abdominal wall tissue on day 7; f is a semi-quantitative analysis of the inflammation level based on Figures c to e, **P ≤ 0.01, ***P ≤ 0.001; g is a semiquantitative analysis of collagen expression based on Figures c to e, **P ≤ 0.01, ***P ≤ 0.001; h is a semi-quantitative analysis of CD31 expression based on Figures c to e, **P≤0.01, ***P≤0.001. FIG9 shows a histological staining image of the biopatch implanted in the defect site 14 days after surgery; wherein, a is a low-resolution schematic diagram of H&E staining on the abdominal wall tissue located on day 14; b is an enlarged image of H&E staining on the abdominal wall tissue located on day 14; c is Masson trichrome staining of the located abdominal wall tissue on day 14; d is CD31 immunohistochemical staining on the abdominal wall tissue located on day 14; e is a semi-quantitative analysis of the inflammation level based on Figures b to d, *P ≤ 0.05, ***P ≤ 0.001; f is a semi-quantitative analysis of collagen expression based on Figures b to d, *P ≤ 0.05, ***P ≤ 0.001; g is a semi-quantitative analysis of CD31 expression based on Figures b to d, *P≤0.05, ***P≤0.001. FIG10 shows a histological staining image of the biopatch implanted in the defect site 28 days after surgery; wherein, a is a low-resolution schematic diagram of H&E staining on the abdominal wall tissue located on day 28; b is a high-resolution schematic diagram of H&E staining on the abdominal wall tissue located on day 28; c is Masson trichrome staining of the located abdominal wall tissue on day 28; d is CD31 immunohistochemical staining on the abdominal wall tissue located on day 28; e is a semi-quantitative analysis of the inflammation level based on Figures b to d, *P ≤ 0.05, ***P ≤ 0.001; f is a semi-quantitative analysis of collagen expression based on Figures b to d, *P ≤ 0.05, ***P ≤ 0.001; g is a semi-quantitative analysis of CD31 expression based on Figures b to d, *P≤0.05, ***P≤0.001. FIG. 11 shows histological staining of a healthy abdominal wall. DETAILED DESCRIPTION Various exemplary embodiments, features and aspects of the present invention will be described in detail below. The word "exemplary" used here means "used as an example, embodiment or illustrative". Any embodiment described here as "exemplary" is not necessarily interpreted as being superior or better than other embodiments. In addition, in order to better illustrate the present invention, numerous specific details are provided in the following specific embodiments. It should be understood by those skilled in the art that the present invention can be implemented without certain specific details. In other examples, methods, means, equipment and steps well known to those skilled in the art are not described in detail in order to highlight the subject matter of the present invention. Unless otherwise stated, the units used in this specification are all international standard units, and the numerical values ​​and numerical ranges appearing in the present invention should be understood to include the inevitable systematic errors in industrial production. In this specification, the word "may" means both performing a certain process and not performing a certain process. In this specification, the references to "some specific / preferred embodiments", "other specific / preferred embodiments", "embodiments", etc., mean that the specific elements (e.g., features, structures, properties and / or characteristics) described in connection with the embodiments are included in at least one embodiment described herein, and may or may not exist in other embodiments. In addition, it should be understood that the elements may be combined in various embodiments in any suitable manner. In this specification, the numerical range expressed using "a numerical value A to a numerical value B" means a range including the endpoints numerical values ​​A and B. In this specification, when "normal temperature" or "room temperature" is used, the temperature may be 10-25°C. <First aspect> A first aspect of the present invention provides a biological patch, comprising: A matrix having a fiber structure and having chelating sites on the surface and / or inside of the matrix; and Active metal ions, based on the chelating sites, the active metal ions are chemically chelated on the surface and / or inside of the matrix; and, The chelating sites are obtained by oxidative polymerization of polyphenolic compounds on the surface and / or inside of the matrix. The present invention can treat abdominal wall injuries by introducing active metal elements with multiple therapeutic effects into the matrix by using polyphenol compounds. The antibacterial efficiency of the biological patch of the present invention is greater than 99%, the symptoms of tissue adhesion are less, and the degree of new blood vessels and collagen maturity is higher through the HIF-α signaling pathway. Therefore, the biological patch has good application prospects in preventing visceral adhesion, bacterial infection and promoting soft tissue regeneration. Matrix The matrix of the present invention has a fiber structure, and the surface and / or the interior of the matrix has chelating sites. The present invention does not specifically limit the source of the matrix, and it can be some commonly used matrix sources in the art. In the present invention, the matrix can be derived from a biodegradable biomaterial, preferably a biomaterial mainly containing collagen, and the collagen can be natural, artificially synthesized, modified or cross-linked, including but not limited to submucosal layer, dermis, pericardium, collagen, gelatin, etc. In some embodiments of the present invention, the matrix is ​​derived from the small intestinal submucosa, preferably from decellularized Small intestinal submucosa, that is, the matrix of the present invention can be prepared using the small intestinal submucosa. In some embodiments of the present invention, the matrix is ​​derived from the bladder submucosa, preferably from the decellularized bladder submucosa, that is, the bladder submucosa can be used to prepare the matrix of the present invention. In some embodiments of the present invention, the matrix is ​​derived from the dermis, preferably from the decellularized dermis, that is, the dermis can be used to prepare the matrix of the present invention. In some embodiments of the present invention, the matrix is ​​derived from the bladder submucosa, preferably from the decellularized bladder submucosa, that is, the bladder submucosa can be used to prepare the matrix of the present invention. In some embodiments of the present invention, the matrix is ​​derived from the pericardium, preferably from the decellularized pericardium, that is, the pericardium can be used to prepare the matrix of the present invention. The submucosa (e.g., small intestinal submucosa), dermis, pericardium, etc. are preferably derived from mammals, such as pigs, cattle, sheep, dogs, cats, etc. In one embodiment of the present invention, the matrix is ​​derived from decellularized porcine small intestinal submucosa. The porcine small intestinal submucosa can be purchased commercially. The porcine small intestinal submucosa is widely available, economical and easy to obtain, and easy to process. The porcine small intestinal submucosa after decellularization has excellent biocompatibility, is rich in collagen and growth factors, can induce cells to diffuse, adhere, grow, and proliferate inward, and promote the repair and regeneration of the tissue defect's own tissue. It is suitable for use as a matrix for preparing the biological patch of the present invention. Therefore, the present invention preferably uses the porcine small intestinal submucosa material matrix prepared by using the porcine small intestinal submucosa as a raw material as a matrix. The present invention does not specifically limit the preparation method of the porcine small intestinal submucosa material matrix, and can be some commonly used preparation methods in the art. Of course, the porcine small intestinal submucosa material matrix can also be purchased commercially. Preferably, the porcine small intestinal submucosa material matrix of the present invention can be prepared according to the preparation method in CN107007886A. In another embodiment of the present invention, the substrate may also be a fiber membrane prepared by using a chemical substance containing collagen. The present invention does not specifically limit the fiber membrane, and it may be a fiber membrane commonly used in the art, such as a non-woven fiber membrane or a spun fiber membrane. The nonwoven fiber membrane of the present invention can be obtained by nonwoven process using a chemical substance containing collagen and one or more combinations of other polymers or their derivatives that are optionally present. The spun fiber membrane of the present invention can be obtained by electrospinning technology, centrifugal spinning technology, hot melt spinning technology, melt electrospinning technology, etc. using a chemical substance containing collagen and one or more combinations of other polymers or their derivatives that are optionally present. Other high molecular polymers or their derivatives may be various commonly used high molecular polymers or their derivatives in the art. For example, they may be selected from one or a combination of two or more natural high molecular polymers. For example, commonly used high molecular polymers or their derivatives may be one or a combination of two or more of cellulose, chondroitin sulfate, chitosan, modified chitosan, fibrin, silk protein, elastin-mimicking peptide polymers, heparin, agar, dextran, alginic acid, cellulose, alginic acid, and starch. Preferably, based on the matrix of the present invention, the biological patch of the present invention contains collagen fibers. Due to the presence of the collagen fibers, the biological patch of the present invention can better play its role. Further, in order to provide the surface and / or interior of the substrate with chelating sites, polyphenol compounds may be used to The matrix is ​​modified so that the polyphenol compounds are oxidatively polymerized on the surface and / or inside of the matrix to obtain chelating sites. The polyphenol compounds have the functions of easy oxidative polymerization and surface modification, and can be oxidatively polymerized on the surface and / or inside of the matrix, thereby generating chelating sites. Specifically, the polyphenolic compound is not particularly limited in the present invention, and can be any feasible polyphenolic compound in the art. Specifically, the polyphenolic compound includes one or a combination of two or more of dopamine, tannic acid, catechol, pyrogallol, gallic acid, and catechin. Active metal ions Based on the chelation sites generated on the matrix, the active metal ions can be chemically chelated on the surface and / or inside of the matrix. The present invention can give the biological patch an antibacterial function by chelating the active metal ions, and help improve the activation ability of blood vessels. In addition, the biological patch of the present invention can be used to treat abdominal wall defects. In some specific embodiments, based on the total mass of the biological patch as 100%, the carbon content is 70-85%, for example: 72%, 75%, 78%, 80%, 82%, etc.; the nitrogen content is 5-10%, for example: 6%, 7%, 8%, 9%, etc.; the oxygen content is 5-20%, for example: 8%, 10%, 12%, 15%, 18%, etc.; the active metal ion content is 0.05-5%, for example: 0.1%, 0.5%, 1%, 2%, 3%, 4%, etc. When the carbon content is 70-85%, the nitrogen content is 5-10%, the oxygen content is 5-20%, and the active metal ion content is 0.05-5%, the efficacy of the prepared biological patch can be more effectively exerted. Specifically, in the biological patch of the present invention, if the active metal ion content is too high, side effects are likely to occur, such as pH over-alkalinity and cytotoxicity caused by ion precipitation; if the active metal ion content is too low, it is difficult to exert a unique biological reaction. Therefore, in the present invention, the active metal ion content is 0.05-5%. Specifically, in the present invention, the active metal ions include one or a combination of two or more of copper ions, calcium ions, manganese ions, zinc ions, chromium ions, cobalt ions, strontium ions, and iron ions. Copper (Cu) has a variety of biologically active functions, such as antibacterial and vasoactive properties. Obviously, the increase in atomic radius and the rich d electron orbits give Cu the ability to chemically coordinate and chelate with many other active molecules or macromolecules, and the copper-loaded biological patch can be successfully prepared. In addition, when the content of active metal ions is 0.05-5%, magnesium ions, strontium ions, manganese ions, iron ions, etc. also have the ability to promote angiogenesis, and calcium ions can provide the ability to promote osteogenesis. Traditional commercial biological patches are limited by their low cell compatibility, which is not conducive to the infiltration and adhesion of native cells, resulting in high risks of visceral tissue adhesion and bacterial infection. However, the biological patch of the present invention has excellent biocompatibility, antibacterial and vascularization capabilities, achieving ideal healing promotion results without tissue adhesion. <Second Aspect> The second aspect of the present invention provides a method for preparing the biological patch according to the first aspect of the present invention, which comprises the step of chemically chelating active metal ions on the surface and / or inside of a substrate using a polyphenol compound. The preparation method of the present invention is simple and easy to implement, and the raw materials are easy to obtain, and is suitable for mass production. In some specific embodiments, the preparation method comprises the following steps: oxidatively polymerizing the polyphenolic compound on the surface and / or inside of the substrate to form chelating sites; Based on the chelating sites, the active metal ions are chemically chelated on the surface and / or inside of the matrix. Specifically, the preparation method comprises the following steps: dissolving the polyphenolic compound in a buffer solution to obtain a solution containing the polyphenolic compound; The substrate is immersed in the solution containing the polyphenol compound to perform oxidative polymerization to obtain an intermediate having a chelating site; preparing a solution containing active metal ions; The intermediate with the chelating site is immersed in a solution containing active metal ions for chemical chelation to obtain a biological patch. The present invention does not specifically limit the buffer solution, and it can be a commonly used buffer solution in the art. Specifically, when the pH value of the buffer solution used to dissolve the polyphenolic compound is 7-9, the obtained biological patch has little irritation to tissues and is conducive to the growth of cells and tissues. When the pH value of the buffer solution used to dissolve the polyphenolic compound is 7.5-8.5, the obtained biological patch has little irritation to tissues and cells and is more suitable for the growth of cells and tissues. Specifically, the buffer solution can be a phosphate buffer solution or a Tris-hydrochloric acid buffer solution, etc. Preferably, considering that the Tris-hydrochloric acid buffer solution has little interference with the biochemical process and does not precipitate with calcium, magnesium ions and heavy metal ions, the present invention preferably uses a Tris-hydrochloric acid buffer solution. In some specific embodiments, the concentration of the polyphenolic compound in the solution containing the polyphenolic compound is 0.1-10 mg mL -1 , for example: 0.5 mg mL -1 , 1mg mL -1 , 3mg mL -1, 5mg mL -1 , 7mg mL -1 etc. Furthermore, when the concentration of polyphenols was 0.5-5 mg·mL -1 When the amount of polyphenol compounds used is more appropriate, the obtained chelating sites are sufficient to chelate active metal ions, so that the function of the biological patch of the present invention can be maximized. Further, the substrate is immersed in the solution containing the polyphenol compound for oxidative polymerization. The present invention does not particularly limit the time of oxidative polymerization, which can be set as needed. Preferably, in order to obtain the desired intermediate with chelating sites to the greatest extent, the time of oxidative polymerization can be 12-36 hours, for example: 15 hours, 18 hours, 20 hours, 22 hours, 25 hours, 28 hours, 30 hours, 32 hours, etc. In some specific embodiments, the mass concentration of the active metal ions in the solution containing active metal ions is 0.01-0.5%, for example, 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, etc. When the mass concentration of the active metal ions is 0.01-0.5%, sufficient active metal ions can be chelated on the matrix, thereby giving the biological patch the desired biocompatibility, antibacterial properties and vascular activity. Furthermore, the intermediate with the chelating site is immersed in a solution containing active metal ions for chemical chelation. The present invention does not specifically limit the chelation time, which can be set as needed. In order to obtain the desired biological patch to the greatest extent, the chemical chelation time is 12-36 hours, for example: 15 hours, 18 hours, 20 hours, 22 hours, 25 hours, 28 hours, 30 hours, 32 hours, etc. <Third Aspect> The third aspect of the present invention provides a use of the biological patch according to the first aspect of the present invention in preparing soft tissue repair products and abdominal wall regeneration and repair products. Hernia and life-threatening intestinal obstruction usually start with abdominal wall injury, and the regeneration of abdominal wall defects is very limited in clinical practice due to the lack of biocompatible, antibacterial and vasoactive materials to treat damaged soft tissue. The present invention can introduce active metal elements with multiple therapeutic effects into biological patches to treat abdominal wall injuries. Compared with other commercially available patches, the biological patch of the present invention has fewer tissue adhesion symptoms when used to treat abdominal wall injuries. Through the HIF-α signaling pathway, the degree of new blood vessels and collagen maturity is high, indicating that the biological patch of the present invention has good application prospects in preventing visceral adhesions, bacterial infections and promoting soft tissue regeneration. Example The embodiments of the present invention will be described in detail below in conjunction with the examples, but those skilled in the art will appreciate that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If no specific conditions are specified in the examples, they are carried out according to normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be obtained commercially. In the examples, SIS biological patch was purchased from Beijing Bohui Ruijin Biotechnology Co., Ltd. (China). Dopamine hydrochloride and copper sulfate (CuSO4) were purchased from Sigma (USA). Tris-HCl was purchased from Amresco (USA). Other reagents were purchased from Beijing Chemical Reagent Co., Ltd. (China). Example 1 As shown in Figure 1a, the SIS biopatch was first cut into a 9 cm × 7 cm shape and immersed in a solution containing 2 mg mL -1 Dopamine hydrochloride solution in Tris-HCl (10 mM L -1 The process was maintained at room temperature with constant stirring at 300 rpm for 24 hours. The removed patch was rinsed three times with deionized water, freeze-dried and named SIS / PDA. Then the SIS / PDA biopatch was immersed in a 0.16wt.% CuSO4 solution and stirred at 300rpm for 24 hours at room temperature. The biopatch was rinsed with deionized water, freeze-dried, and named SIS / PDA / Cu. The content of each element in the biopatch was detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biopatch as 100%, the content of carbon element was 73.63%, the content of nitrogen element was 8.55%, the content of oxygen element was 16.75%, and the content of copper element was 1.07%. Example 2 First, the SIS biopatch was cut into a 9 cm × 7 cm shape and soaked in 5 mg mL -1 Dopamine hydrochloride solution in Tris-HCl (10 mM L -1 The process was maintained at room temperature with constant stirring at 300 rpm for 12 hours. The removed patch was rinsed three times with deionized water, freeze-dried and named SIS / PDA. Then the SIS / PDA biopatch was immersed in a 0.5wt.% CuSO4 solution and stirred at 300rpm for 36 hours at room temperature. The biopatch was rinsed with deionized water, freeze-dried, and named SIS / PDA / Cu-2. The content of each element in the biopatch was detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biopatch as 100%, the content of carbon element was 71.57%, the content of nitrogen element was 8.13%, the content of oxygen element was 17.73%, and the content of copper element was 2.57%. Example 3 First, the SIS biopatch was cut into a 9 cm × 7 cm shape and immersed in a solution containing 0.1 mg mL -1 Dopamine hydrochloride solution in Tris-HCl (10 mM L -1 The process was maintained at room temperature with a constant speed of 300 rpm. The patch was stirred for 36 hours and then rinsed with deionized water for three times, freeze-dried and named SIS / PDA. Then the SIS / PDA biological patch was immersed in a 0.01wt.% CuSO4 solution and stirred at 300rpm for 12 hours at room temperature. The patch was rinsed with deionized water, freeze-dried, and named SIS / PDA / Cu-3. The content of each element in the biological patch was detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biological patch as 100%, the content of carbon element was 75.34%, the content of nitrogen element was 8.98%, the content of oxygen element was 15.37%, and the content of copper element was 0.31%. Example 4 First, the SIS biopatch was cut into a 9 cm × 7 cm shape and immersed in a solution containing 0.1 mg mL -1 Dopamine hydrochloride solution in Tris-HCl (10 mM L -1 The process was maintained at room temperature with constant stirring at 300 rpm for 12 hours. The removed patch was rinsed three times with deionized water, freeze-dried and named SIS / PDA. Then the SIS / PDA biological patch was immersed in a 0.01wt.% MnCl2 solution and stirred at 300rpm for 12 hours at room temperature. The patch was rinsed with deionized water, freeze-dried, and named SIS / PDA / Mn. The content of each element in the biological patch was detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biological patch as 100%, the content of carbon element was 78.43%, the content of nitrogen element was 8.32%, the content of oxygen element was 13.08%, and the content of manganese element was 0.17%. Example 5 First, the SIS biopatch was cut into a 9 cm × 7 cm shape and soaked in 2 mg mL -1 The process was kept at room temperature with constant stirring at 300 rpm for 24 hours. The removed patch was rinsed three times with deionized water, freeze-dried and named SIS / TA. The SIS / TA biological patch was then immersed in a 0.3wt.% FeCl3 solution and stirred at 300rpm for 24 hours at room temperature. The patch was rinsed with deionized water, freeze-dried, and named SIS / TA / Fe. The content of each element in the biological patch was detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biological patch as 100%, the content of carbon element was 80.71%, the content of nitrogen element was 7.67%, the content of oxygen element was 8.38%, and the content of iron element was 3.24%. Example 6 First, the SIS biopatch was cut into a 9 cm × 7 cm shape and soaked in 10 mg mL -1 Gallic acid aqueous solution (100 mL) was added. The process was kept at room temperature with constant stirring at 300 rpm for 12 hours. The removed patch was rinsed three times with deionized water, freeze-dried and named SIS / GA. The SIS / GA biopatch was then immersed in a 0.5wt.% MgCl2 solution and stirred at 300 rpm for 36 hours at room temperature. The removed patch was rinsed with deionized water, freeze-dried, and named SIS / GA / Mg. The contents of each element in the biopatch were detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biopatch as 100%, the content of carbon was 79.64%, the content of nitrogen was 7.88%, the content of oxygen was 10.27%, and the content of magnesium was 2.21%. Example 7 First, the SIS biopatch was cut into a 9 cm × 7 cm shape and soaked in 1 mg mL -1 Gallic acid aqueous solution (100 mL). The process was maintained at room temperature with constant stirring at 300 rpm for 24 hours. The removed patch was rinsed three times with deionized water, freeze-dried and named SIS / GA. The SIS / GA biopatch was then immersed in a 0.1wt.% CaCl2 solution and stirred at 300rpm for 24 hours at room temperature. The removed patch was rinsed with deionized water, freeze-dried, and named SIS / GA / Ca. The contents of each element in the biopatch were detected by X-ray photoelectron spectroscopy (XPS for short), wherein, based on the total mass of the biopatch as 100%, the content of carbon was 83.68%, the content of nitrogen was 7.64%, the content of oxygen was 8.55%, and the content of calcium was 0.13%. Performance Testing (Test Method) 1. Morphological and mechanical evaluation The morphology of the SIS / PDA / Cu biopatch was studied by scanning electron microscopy (SEM, S4800, Hitachi, Japan), and elemental analysis was performed by energy dispersive spectrometer (EDS). The patch was cut into 1 cm × 1 cm shapes for X-ray photoelectron spectroscopy (XPS, ESCLAB250Xi VG Scientific, MA). Water contact analysis was performed by dropping 10 μL of water and recording the data using a video contact angle meter (JC2000C1, China). The 3 cm × 1 cm fixed-shape patch (~100 μm thickness) was loaded into a universal testing machine (EUT6502, Shenzhen Sansi Co., Ltd., China) and the mechanical strength was studied at room temperature with a tensile speed of 5 mm min -1 . 2. DPPH scavenging ability assessment DPPH (Sigma, USA) was dissolved in ethanol at a concentration of 0.05 mg mL -1 The patch (1 cm × 1 cm) was immersed in 10 mL of DPPH solution and placed in the dark for 24 hours. The supernatant was then recovered and the absorbance at 517 nm was recorded. DPPH removal efficiency (%) was calculated as follows: (A B -A M ) / A B ×100%. Among them, A B refers to the absorbance of the DPPH solution after standing for 24 hours, while A M It refers to the absorbance of the DPPH solution that reacts with the patch. 3. Evaluation of pH and ion release The SIS / PDA / Cu biopatch was cut into a 1 cm × 1 cm shape and then immersed in 10 mL of deionized water at 37 °C for 14 days. The supernatant was removed at regular intervals (1, 4, 7, and 14 days) and the pH and Cu concentrations were measured using ICP-MS (IPCS-7700, Shimadzu, Japan). 2+ Detection. 4. Antibacterial evaluation test Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) were purchased from Beijing Sanyao Technology Development Co., Ltd. (China). The original bacteria were first revived according to the product instructions, and then cultured in Luria-Bertani (LB) medium at 37°C for 24 hours, and the bacterial concentration was counted using a turbidimeter. 5 The bacterial units of CFU and the biological patches of 1 cm × 1 cm were cultured in 1 mL LB medium at 37 ° C for 24 hours, and then 100 μL of the supernatant was dropped on a sterile agar plate and cultured at 37 ° C for 24 hours to observe the colony formation. At the same time, 100 μL of the supernatant was extracted and placed in a 96-well plate, and the optical density (OD) value was read at 600 nm using a multifunctional microplate reader (Bio-Rad 680, USA). The bacterial survival rate (%) was calculated as follows: 1-(OD 对照 -OD 补片 ) / (OD 对照 -OD 空白 ). Among them, OD 对照 It refers to the OD of bacteria when they grow under normal conditions. 600 , O.D. 补片 When the patch is co-cultured with bacteria OD600, OD 空白 It refers to the OD when the culture medium is sterile. 600 In addition, the biopatch collected after co-culture with bacteria was rinsed three times and then fixed with 10% PFA. The dehydrated biopatch was observed by SEM. 5. Cytocompatibility assay and vascular analysis and evaluation L929 mouse fibroblasts were used to evaluate the cytotoxicity of the biopatch. L929 cells were seeded on the biopatch at a density of 2000 cells / well. After 24 hours of culture, the culture medium was discarded, and the cells were incubated with calcein-AM / PI (Aladdin, China), CCK-8 (Dojindo, Japan), and rhodamine B-labeled phalloidin / DAPI (Sigma, USA), and cell proliferation was observed under a laser confocal scanning microscope (CLSM, TCS SP8, Leica) and a microplate reader. At the same time, the primary antibody HIF-α (ab179483, Abcam, UK) and CD31 (ab28364, Abcam, UK) were used for immunofluorescence staining together with the secondary antibodies labeled with rhodamine B and FITC, respectively. Among them, the excitation wavelength of calcein is 490nm and the emission wavelength is 515nm, the excitation wavelength of PI is 530nm and the emission wavelength is 580nm, the excitation wavelength of rhodamine B is 544nm and the emission wavelength is 576nm, the excitation wavelength of DAPI is 358nm and the emission wavelength is 461nm, and the excitation wavelength of FITC is 488nm and the emission wavelength is 525nm. CCK-8 records OD at 450nm 450 value. 6. Animal Experimental Abdominal Wall Defect and Its Repair All animal experiments were in compliance with the Tianjin Medical Laboratory Animal Management Standards, and the animal protocols were approved by the Experimental Animal Care and Use Committee of Yishengyuan Gene Technology (Tianjin) Co., Ltd. In a sterile operating room, 28 rats were anesthetized with isoflurane. A 2-cm-long sagittal incision was made in the abdominal wall, and an injury wound (1 cm long) was created to simulate a surgical abdominal wall defect. The rats were randomly divided into 3 groups, with 9 rats in each group. Group I used a commercially available PP mesh (produced by Beijing Bohui Ruijin Biotechnology Co., Ltd.) cut into 2 cm × 1 cm and implanted into the wound surface. Group II used a commercially available SIS biological patch (produced by Beijing Bohui Ruijin Biotechnology Co., Ltd.) cut into 2 cm × 1 cm and implanted into the wound surface. Group III used a SIS / PDA / Cu biological patch cut into 2 cm × 1 cm and implanted into the injury area. Healthy SD rats were taken as normal pathological controls. All rats were fixed with nylon sutures in sequence after surgery and fed freely. At specific times (7, 14, and 28 days) after surgery, the rats were killed to collect the abdominal wall. The obtained tissues were fixed with formalin, dehydrated, and embedded in paraffin for sectioning. The sections were stained with H&E, Masson's trichrome and CD31 antibody (ab182981, abcam, UK). The stained sections were captured on a digital slide scanner (Nanozoomer, Hamamatsu, Japan), and protein expression was semi-quantitatively analyzed by counting specific gray levels based on Image Pro Plus software. 7. Statistical analysis Data are expressed as mean ± standard deviation (SD). Statistical analysis was performed using one-way analysis of variance (ANOVA). *Differences between groups with p ≤ 0.05 were considered statistically significant, **p ≤ 0.01 were considered highly significant, and ***p ≤ 0.001 were considered extremely significant. (Test results) 1. Morphological test results From the SEM images, it can be seen that the native specific collagen fibers such as thick fibers (i.e., type III collagen) and thin fibers (i.e., type I collagen) can be clearly seen, while the dopamine hydrochloride deposition and Cu 2+ Chelation did not destroy the morphology of the SIS substrate (Figure 1b). After the introduction of dopamine hydrochloride, the originally white or light yellow SIS turned black due to the polymerization of dopamine on it, and the Cu in the SIS / PDA / Cu biopatch 2+ After chelation, the copper element signal was clearly seen (Figure 1c), indicating that we successfully prepared A SIS-based biological patch containing copper was developed. 2. Physical and mechanical properties test results The performance of the SIS / PDA / Cu biopatch was studied through chemical and physical experiments. XPS showed specific elements such as C, O, N, and Cu in the binding energy range, while in the high-resolution Cu XPS curve, the copper element was in the form of copper ions (Cu 2+ ) (Figure 2a), indicating that there is a chemical coordination of Cu-O bonding between polyphenols and Cu. In the water contact test to detect the hydrophilicity of the materials, the water contact angle of the SIS biopatch was 49.75±5.23°, and that of the SIS / PDA biopatch decreased to 32.4±2.37° due to the inherent hydrophilicity of the polyphenol compound modification strategy, while there was no difference between the SIS / PDA / Cu biopatch and SIS / PDA (Figure 2b). The mechanical properties of the SIS biopatch are shown in Figure 2c-f. The UTS and elongation at break of SIS are 17.40±2.44MPa and 19.97±2.06%, respectively. After modification with dopamine hydrochloride, the tensile strengths of the SIS / PDA biopatch and the SIS / PDA / Cu biopatch are 38.98±6.18MPa and 31.56±11.18MPa, respectively, and the elongation at break is about 40%. Similarly, the Young's modulus increases after modification with dopamine hydrochloride (e.g., from about 193.30MPa to about 320.60MPa) (Figure 2c-f), which may be due to the hydrogen bonding interaction and other chemical bonds between catechol in the polyphenolic compound and collagen in SIS. 3. DPPH removal ability test results Polyphenolic compounds can also improve the scavenging ability of SIS-based biopatch to ROS. From the perspective of DPPH free radical scavenging rate, the scavenging rate of SIS is only 13.68±2.96%, while the scavenging rates of SIS / PDA and SIS / PDA / Cu biopatch are 68.32±4.78% and 47.46±4.45, respectively (Figure 3). The introduction of Cu into SIS / PDA / Cu biopatch reduces the DPPH scavenging efficiency, which confirms the chelation effect of Cu-O binding and consumes the proportion of catechol groups. Under most tissue injury conditions, the ability of implanted materials to scavenge ROS can alleviate local severe oxidative stress. SIS / PDA and SIS / PDA / Cu biopatch show advantages in this stress relief and are more conducive to tissue remodeling and regeneration. 4. Antibacterial performance test results Copper has excellent antibacterial properties, and its mechanism can be attributed to the internalization of copper ions by bacteria, which further destroys the integrity of the biofilm and inhibits metabolic enzymes from catalyzing DNA degradation and destruction. Therefore, copper is introduced into SIS-based materials to prepare a powerful antibacterial biological patch to treat vulnerable areas of abdominal wall injuries. First, the SIS / PDA / Cu biopatch, SIS biopatch, and SIS / PDA biopatch were cultured with two different types of bacteria (i.e., Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus) for 24 hours, and then the supernatant was collected and placed on a sterile agar plate for 24 hours. Similarly, the OD value of the supernatant at 600 nm was recorded. From the image, it can be seen that the SIS biopatch and SIS / PDA biopatch have Escherichia coli and Staphylococcus aureus colonies formed, while the SIS / PDA / Cu biopatch agar plate was almost clean with no obvious bacteria (Figure 4a). According to the OD value, the antibacterial efficiency of the SIS / PDA / Cu biopatch against Escherichia coli was 99.37±0.43%, and the antibacterial efficiency against Staphylococcus aureus was 99.44±0.44%, showing greater superiority than other biopatch (Figure 4b). In addition, the bacterial morphology on the SIS / PDA / Cu biopatch was able to deform and collapse, leading to bacterial death (Figure 4c). 5. Ion release test results In the sterile deionized water in which the SIS / PDA / Cu biopatch was immersed, Cu 2+ The release potential did not affect the pH value (Figure 5a). Cu 2+ The release behavior showed that although a burst release (27.33 ± 7.02 ppb) occurred on the first day, a constant release (up to 40.93 ± 7.88 ppb) was achieved for 14 days (Figure 5b). These results indicate that we have prepared a durable antimicrobial biopatch with long-term bactericidal potential. 6. Study on the biological activity of SIS / PDA / Cu biological patch The bioactivity of the SIS / PDA / Cu biopatch was evaluated by cytocompatibility and vascular analysis. In the live / dead staining images, L929 fibroblasts on the SIS-based biopatch were all green fluorescent (indicating live cells) and spindle-shaped, which was not much different from those cells cultured on the culture plate (i.e., the control group) (Figure 6a), and CCK-8 data showed that the cell survival rate was over 90% (Figure 6b), demonstrating that these biopatches have good cytocompatibility. Figure 6c shows the cytoskeleton staining of L929 on the matrix, and by using Image J to semi-quantitatively analyze the spreading area, SIS / PDA has a higher spreading area than SIS (18.84±2.87μm 2 vs.13.26±4.51μm 2 ), attributed to the affinity of PDA modification, the SIS / PDA / Cu biopatch had no adverse effect on cell adhesion ( Figure 6d ). As an essential trace element for the human body, copper not only has good antibacterial effects, but also promotes vascular capacity and the formation of new blood vessels. Copper can activate HIF-α receptors to promote angiogenesis. Here, we performed immunofluorescence staining of key markers including HIF-α and CD31 on the biological patch (Figure 6e). By semi-quantitative analysis of fluorescence intensity, the SIS / PDA / Cu biological patch had significantly higher expression in both HIF-α and CD31 (HIF-α: 1.88 times that of the control and 1.71 times that of SIS; CD31: 2.24 times that of the control group and 1.66 times that of the SIS group). Endogenous bioactive factors such as VEGF and TGF-β in the SIS biological patch also contribute to CD31 expression (CD31: 1.35 times that of the control group) (Figure 6f). The results show that the SIS / PDA / Cu biological patch has good cell compatibility. As a cell adhesion and growth carrier, it is conducive to cell growth and induction of vascularization, which is of great significance for the repair of abdominal wall injuries. 7. Abdominal wall defect and its repair A sagittal incision (1 cm long) was made on the abdominal wall of SD rats to simulate surgical abdominal wall defects. Different patches (including commercially available PP patches (Figure 7), commercially available SIS biological patches, and SIS / PDA / Cu biological patches) were molded into regular sizes (2 cm × 1 cm) and then implanted into the defect site. The patches were then fixed with sutures (Figure 8a) to evaluate abdominal wall regeneration. At regular intervals, the harvested tissues were dehydrated and paraffin-embedded for sectioning and pathological staining. As shown in Figure 8b-e, 7 days after surgery, the commercially available PP patch had obvious inflammation at the site of the site, the tissue was infiltrated by neutrophils (H&E staining), collagen formation was less (Masson trichrome staining), and vascularization was not obvious (CD31 staining), but due to good biocompatibility and endogenous bioactive factors (such as VEGF, TGF-β), the commercially available SIS biopatch and SIS / PDA / Cu biopatch had moderate inflammation, which was conducive to collagen expression and vascular activation (SIS collagen expression was 4.43 times and 2.24 times that of PP patch, and CD31 was 4.43 times and 2.24 times that of PP patch). In addition to the in vitro study proving vascular dynamics, the SIS / PDA / Cu biopatch also showed that the level of vascularization in the abdominal wall at 7 days was 1.58 times that of SIS (Figure 8f-h). Fourteen days after surgery, histological staining is shown in Figure 9. During this period, there were no comparable differences in H&E staining of all implants, as shown in Figure 9. Due to the long implantation period, no obvious neutrophils were available (Figure 9a, b, e). In Masson trichrome staining, the commercial SIS biopatch and SIS / PDA / Cu biopatch had more collagen deposition than the commercial PP patch (SIS was approximately 2.23 times that of PP, and SIS / PDA / Cu was approximately 2.68 times that of PP), and the CD 31 expression of the commercial SIS biopatch and SIS / PDA / Cu biopatch was also much higher than that of the commercial PP patch (SIS was approximately 2.31 times that of PP, and SIS / PDA / Cu was approximately 3.32 times) (Fig. 9c, d, f, g), which indicates that the performance of SIS / PDA / Cu biopatch for abdominal wall repair is very superior. 28 days after surgery, histological staining is shown in Figure 10. Due to the lack of the function of promoting collagen deposition, the commercially available PP patch caused stress on the surrounding abdominal wall due to continuous dynamic movement, resulting in strain and tear of the abdominal wall (Figure 10a), while the collagen expression of the commercially available SIS biological patch and SIS / PDA / Cu biological patch was about 3.30 times that of the commercially available PP patch, and the collagen was arranged continuously and regularly at the injury site (Figure 10b-g), and the vascularization was complete, which was very similar to the healthy abdominal wall (Figure 11). The present invention utilizes the characteristics of polyphenol compounds that are easy to polymerize and deposit, chemically chelates active metal ions with a matrix, and prepares a biological patch with good antibacterial and vascular activity. This preparation process not only improves the mechanical strength of SIS, but also has an antibacterial efficiency of more than 99%, significantly improves vascular activity, and has a variety of tissue engineering therapeutic effects. In the established SD rat abdominal wall defect model, the SIS / PDA / Cu biological patch showed good biocompatibility, collagen maturation and neovascularization outcomes, and there was no visceral adhesion and edema in the body, showing great prospects for use in abdominal wall regeneration and soft tissue fields. It should be noted that, although the technical solution of the present invention is introduced with specific examples, those skilled in the art will appreciate that the present invention should not be limited thereto. The embodiments of the present invention have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments. The selection of terms used herein is intended to best explain the principles of the embodiments, practical applications, or technical improvements in the market, or to enable other persons of ordinary skill in the art to understand the embodiments disclosed herein.

Claims

1. A biological patch, characterized in that: include: A matrix having a fiber structure and having chelating sites on the surface and / or inside of the matrix; as well as, Active metal ions, based on the chelating sites, the active metal ions are chemically chelated on the surface and / or inside of the matrix; and, The chelating sites are obtained by oxidative polymerization of polyphenolic compounds on the surface and / or inside of the matrix.

2. The biological patch according to claim 1, characterized in that: Taking the total mass of the biological patch as 100%, the content of carbon element is 70-85%, the content of nitrogen element is 5-10%, the content of oxygen element is 5-20%, and the content of active metal ions is 0.05-5%.

3. The biological patch according to claim 1 or 2, characterized in that: The matrix is ​​derived from a biodegradable biomaterial, preferably comprising collagen; and / or The active metal ions include one or a combination of two or more of copper ions, calcium ions, manganese ions, zinc ions, chromium ions, cobalt ions, strontium ions, and iron ions.

4. The biological patch according to any one of claims 1 to 3, characterized in that: The polyphenolic compounds include one or a combination of two or more of dopamine, tannic acid, catechol, pyrogallol, gallic acid and catechin.

5. A method for preparing a biological patch according to any one of claims 1 to 4, characterized in that: The method comprises the steps of utilizing polyphenol compounds to chemically chelate active metal ions on the surface and / or inside of a substrate.

6. The preparation method according to claim 5, characterized in that: The preparation method comprises the following steps: oxidatively polymerizing the polyphenolic compound on the surface and / or inside of the substrate to form chelating sites; Based on the chelating sites, the active metal ions are chemically chelated on the surface and / or inside of the matrix.

7. The preparation method according to claim 6, characterized in that: The preparation method comprises the following steps: dissolving the polyphenolic compound in a buffer solution to obtain a solution containing the polyphenolic compound; The substrate is immersed in the solution containing the polyphenol compound to perform oxidative polymerization to obtain an intermediate having a chelating site; preparing a solution containing active metal ions; The intermediate with the chelating site is immersed in a solution containing active metal ions for chemical chelation to obtain a biological patch.

8. The preparation method according to claim 7, characterized in that: In the solution containing polyphenolic compounds, the concentration of the polyphenolic compounds is 0.1-10 mg mL -1 and / or, In the solution containing active metal ions, the mass concentration of active metal ions is 0.01-0.5%.

9. The preparation method according to claim 7 or 8, characterized in that: The oxidative polymerization time is 12-36 hours; and / or The chemical chelation time is 12-36 hours.

10. Use of the biological patch according to any one of claims 1 to 4 in preparing soft tissue repair products and abdominal wall regeneration and repair products.

Citation Information

Patent Citations

  • Preparation method and application of antimicrobial and anti-degradable small instestinal mucous accellular substrate

    CN103751844A

  • Preparation method of nano-silver functionalized dopamine-sericin composite thin film as well as product and application thereof

    CN106977757A

  • Antibacterial collagen membrane and preparation method thereof

    CN111671976A

  • Metal polyphenol collagen membrane material as well as preparation method and application thereof

    CN112316204A

  • Antibacterial polymer raw material and its production

    JP2000204182A